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Pseudomonas aeruginosa as a Human
Pathogen
Pseudomonas aeruginosa, an increasingly
prevalent opportunistic human pathogen, is the
most common gram-negative bacterium found in
nosocomial infections. P. aeruginosa is responsi-
ble for 16% of nosocomial pneumonia cases (1),
12% of hospital-acquired urinary tract infections
(2), 8% of surgical wound infections (3), and 10%
of bloodstream infections (4). Immunocompro-
mised patients, such as neutropenic cancer and
bone marrow transplant patients, are particular-
ly susceptible to opportunistic infections. In this
group of patients, P. aeruginosa is responsible
for pneumonia and septicemia with attributable
deaths reaching 30% (5,6). P. aeruginosa is also
one of the most common and lethal pathogens
responsible for ventilator-associated pneumonia
in intubated patients (7), with directly attribut-
able death  rates reaching 38% (8). In burn
patients,  P. aeruginosa bacteremia has declined
as a result of better wound treatment and dietary
changes (removal of raw vegetables, which can
be contaminated with P. aeruginosa, from the
diet) (3). However, P. aeruginosa outbreaks in
burn units are still associated with high (60%)
death rates (9). In the expanding AIDS
population,  P. aeruginosa bacteremia is associ-
ated with 50% of deaths (10). Cystic fibrosis (CF)
patients are characteristically susceptible to
chronic infection by P. aeruginosa, which is
responsible for high rates of illness and death in
this population (11). The capacity of P. aeruginosa
to produce such diverse, often overwhelming
infections is due to an arsenal of virulence factors
(Figure 1). Many extracellular virulence
factors secreted by P. aeruginosa have been
shown to be controlled by a complex regulatory
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Pseudomonas aeruginosa is a bacterium responsible for severe nosocomial
infections, life-threatening infections in immunocompromised persons, and chronic
infections in cystic fibrosis patients. The bacterium’s virulence depends on a large
number of cell-associated and extracellular factors. Cell-to-cell signaling systems
control the expression and allow a coordinated, cell-density–dependent production
of many extracellular virulence factors. We discuss the possible role of cell-to-cell
signaling in the pathogenesis of P. aeruginosa infections and present a rationale for
targeting cell-to-cell signaling systems in the development of new therapeutic
approaches.
Figure 1. Virulence factors of Pseudomonas
aeruginosa. P. aeruginosa has both cell-associated
(flagellum, pilus, nonpilus adhesins, alginate/
biofilm, lipopolysaccharide [LPS]) and extracellular
virulence factors (proteases, hemolysins, exotoxin A,
exoenzyme S, pyocyanin).
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     - phospholipase C
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circuit involving cell-to-cell signaling systems
that allow the bacteria to produce these factors in
a coordinated, cell-densitydependent manner
(12). In this article we describe major
virulence factors of P. aeruginosa and the
possible involvement of cell-to-cell signaling in
the pathogenesis of acute P. aeruginosa infection.
We also summarize data suggesting that these
regulatory systems could be exploited for the
design of therapeutic interventions.
Pathogenesis of P. aeruginosa Infections
P. aeruginosa (family Pseudomonadaceae),
an aerobic, motile, gram-negative rod able to
grow and survive in almost any environment,
lives primarily in water, soil, and vegetation.
However, despite abundant opportunities for
spread, P. aeruginosa rarely causes com-
munity-acquired infections in immunocompe-
tent patients. As a result, the pathogen is
viewed as opportunistic. The different phases of
P. aeruginosa infection are shown in Figure 2.
Colonization: The Predominant Role of Cell-
Associated Virulence Factors
To initiate infection, P. aeruginosa usually
requires a substantial break in first-line
defenses. Such a break can result from breach or
bypass of normal cutaneous or mucosal barriers
(e.g., trauma, surgery, serious burns, or
indwelling devices), disruption of the protective
balance of normal mucosal flora by broad-
spectrum antibiotics, or alteration of the
immunologic defense mechanisms (e.g., in
chemotherapy-induced neutropenia, mucosal
clearance defects from cystic fibrosis, AIDS, and
diabetes mellitus).
The first step in P. aeruginosa infections is
colonization of altered epithelium. The pathogen
colonizes the oropharynx of up to 6% and is
recovered from the feces of 3% to 24% of healthy
persons (2). In contrast, up to 50% of hospitalized
patients are at high risk for P. aeruginosa
colonization (2). Adherence of P. aeruginosa to
epithelium is probably mediated by type 4 pili
similar to those of Neisseria gonorrhoeae (13).
Several other nonpilus adhesins responsible for
the binding to mucin have been described, but
their role in the infection process remains
unclear (14). Flagella, which are primarily
responsible for motility, may also act as adhesins
to epithelial cells (15).
From Colonization to Acute Infection: The
Role of Extracellular Virulence Factors
P. aeruginosa produces several extracellular
products that after colonization can cause
extensive tissue damage, bloodstream invasion,
and dissemination (Figure 1). In vivo studies
have shown that mutants defective in the
production of exotoxin A, exoenzyme S, elastase,
or alkaline protease are essential for maximum
virulence of P. aeruginosa; however, the relative
contribution of a given factor may vary with the
type of infection (16). Many of these factors are
controlled by regulatory systems involving cell-
to-cell signaling. We will summarize the known
biologic effects of the most-studied extracel-
lular virulence factors associated with acute
P. aeruginosa infection.
Exotoxin A is produced by most P. aeruginosa
strains  that cause clinical infections. Like
Figure 2. Model of the different phases of
Pseudomonas aeruginosa infection. After an initial
colonization phase, mostly dependent on cell-
associated virulence factors, the infectious process
evolves either to a chronic infection characterized by
low production of extracellular virulence factors or to
an acute infection characterized by high production of
cell-to-cell signaling dependent virulence factors.
During acute exacerbation of chronic infection, the
production of cell-to-cell signaling dependent
virulence factors is highly increased.553 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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diphtheria toxin, P. aeruginosa exotoxin A
catalyzes ADP-ribosylation and inactivation of
elongation factor 2, leading to inhibition of
protein biosynthesis and cell death (17).
Exotoxin A is responsible for local tissue damage,
bacterial invasion (18), and (possibly) immuno-
suppression (19). Purified exotoxin A is highly
lethal for mice which supports its role as a major
systemic virulence factor of P. aeruginosa (18).
Exoenzyme S is also an ADP-ribosyl
transferase, but unlike exotoxin A, it preferen-
tially ribosylates GTP-binding proteins such as
Ras (20). This exoproduct is responsible for direct
tissue destruction in lung infection (21) and may
be important for bacterial dissemination (22).
Two hemolysins, phospholipase C and
rhamnolipid, produced by P. aeruginosa, may act
synergistically to break down lipids and lecithin.
Both may contribute to tissue invasion by their
cytotoxic effects. Rhamnolipid, a rhamnose-
containing glycolipid biosurfactant, has a
detergentlike structure and is believed to
solubilize the phospholipids of lung surfactant,
making them more accessible to cleavage by
phospholipase C (23). The resulting loss of lung
surfactant may be responsible for the atelectasis
associated with chronic and acute P. aeruginosa
lung infection (24). Rhamnolipid also inhibits the
mucociliary transport and ciliary function of
human respiratory epithelium (25). However,
the relative role of rhamnolipid in acute or
chronic infection is not known.
Proteases are assumed to play a major role
during acute P. aeruginosa infection. P. aeruginosa
produces several proteases including LasB
elastase, LasA elastase, and alkaline protease
(12). The role of alkaline protease in tissue
invasion and systemic infections is unclear;
however, its role in corneal infections may be
substantial (26,27). The ability of P. aeruginosa
to destroy the protein elastin is a major virulence
determinant during acute infection. Elastin is a
major part of human lung tissue and is
responsible for lung expansion and contraction.
Moreover, elastin is an important component of
blood vessels, which rely on it for their resilience.
The concerted activity of two enzymes, LasB
elastase and LasA elastase, is responsible for
elastolytic activity (28). Elastolytic activity is
believed to destroy elastin-containing human
lung tissue and cause the pulmonary hemor-
rhages of invasive P. aeruginosa infections.
LasB elastase is a zinc metalloprotease that
acts on a number of proteins including elastin.
LasB  elastase is highly efficient, with a
proteolytic  activity approximately 10 times that of
P. aeruginosa alkaline protease and an activity
toward casein approximately four times that of
trypsin (28). The LasA elastase is a serine
protease that acts synergistically with LasB
elastase to degrade elastin. LasA elastase nicks
elastin, rendering it sensitive to degradation by
other proteases such as LasB elastase, alkaline
protease, and neutrophil elastase (28). Both
LasB elastase and LasA elastase have been
found in the sputum of CF patients during
pulmonary exacerbation (29). However, the role
of LasB elastase in tissue destruction during the
chronic phase of CF is less clear. It has been
postulated that during this phase, antibodies
present in high titers neutralize LasB elastase,
and elastin damaged by minute amounts of LasA
is degraded mostly by neutrophil elastase (28).
LasB elastase degrades not only elastin but also
fibrin and collagen (30). It can inactivate
substances such as human immunoglobulins G
and A (31), airway lysozyme (32), complement
components (33), and substances involved in
protecting the respiratory tract against pro-
teases such as a-1-proteinase inhibitor (34) and
bronchial mucus proteinase inhibitor (35).
Therefore, LasB elastase not only destroys tissue
components but also interferes with host defense
mechanisms. Studies in animal models show
that mutants defective in LasB elastase
production are less virulent than their parent
strains (16,36,37), which supports the role of
LasB elastase as a virulence factor.
Cell-to-Cell Signaling: A Global Regulation
System of P. aeruginosa Extracellular
Virulence Factors
Cell-to-Cell Signaling Systems
P. aeruginosa appears to control the
production of many of its extracellular virulence
factors by a mechanism that monitors bacterial
cell density and allows communication between
bacteria by cell-to-cell signaling. Bacteria are able
to sense their environment, process information,
and react appropriately; however, their ability to
sense their own cell density, to communicate554 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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with each other, and to behave as a population
instead of individual cells has only recently been
understood (38,39). This phenomenon, called
quorum-sensing or cell-to-cell signaling, is a
generic phenomenon described in many gram-
negative (40) and gram-positive bacteria (41).
The first cell-to-cell signaling system
described is the lux system, responsible for the
cell-densitydependent control of biolumines-
cence genes by the marine bacteria Vibrio
fischeri (38). Cell-to-cell signaling systems of
gram-positive bacteria involve peptide phero-
mones as signals (41). In contrast, cell-to-cell
signaling systems of gram-negative bacteria,
with the exception of Ralstonia solanacearum, in
which an endogenous fatty acid derivative has
been suggested as a cell-to-cell signal (42,43), are
composed of a small molecule called an
autoinducer, which is synthesized by a LuxI-
type autoinducer synthase and a LuxR-type
transcriptional activator protein (R-protein)
(Figure 3) (38). The various autoinducers
described in gram-negative bacteria are
homoserine lactone-based molecules that differ
between one another in length and substitutions
on their acyl side chains. At low cell density,
autoinducer is synthesized at basal levels and is
thought to diffuse into the surrounding media,
where it becomes diluted. With increasing cell
density, the intracellular concentration of
autoinducer increases until it reaches a
threshold concentration. At this critical concen-
tration, the autoinducer has been proposed to
bind to a specific R-protein (40). The R-protein
itself is not active without the corresponding
autoinducer, and it is the R-protein/autoinducer
complex that is proposed to bind to specific DNA
sequences upstream of target genes enhancing
their transcription (44,45). The resulting
increase in expression of these genes can reach
1,000-fold. The autoinducer, therefore, allows
the bacteria to communicate with each other
(cell-to-cell signaling), to sense their own density
(quorum-sensing), and together with a tran-
scriptional activator to express specific genes  as
a population instead of individual cells.
The las Cell-to-Cell Signaling System of
P. aeruginosa
The first cell-to-cell signaling system
described in P. aeruginosa was shown to regulate
expression of LasB elastase and was therefore
named the las system (46). The las cell-to-cell
signaling system is composed of lasI, the
autoinducer synthase gene responsible for the
synthesis of 3-oxo-C12-HSL (N-[3-oxodode-
canoyl]-L-homoserine lactone, previously named
PAI-1 or OdDHL), and the lasR gene that codes
for a transcriptional activator protein (Figure 4)
(47,48). The las cell-to-cell signaling system
regulates lasB expression and is required for
optimal production of other extracellular
virulence factors such as LasA protease and
exotoxin A (49). LasI is the most sensitive gene to
activation by LasR/3-oxo-C12-HSL (50). The
preference for the lasI promoter allows an initial
rapid rise in autoinducer synthesis, which
increases the amount of 3-oxo-C12-HSL avail-
able to bind to LasR. This autoinduction
hierarchy is responsible for a dramatic increase
of expression of virulence genes (such as lasB)
once a critical cell density has been reached.
Recently, the las system has also been shown to
activate the xcpP and xcpR genes that encode
proteins of the P. aeruginosa secretory pathway
(51). 3-oxo-C12-HSL alone has been suggested to
contribute to the virulence of P. aeruginosa
because it has some immunomodulatory activity
(52). The las cell-to-cell signaling system is
positively controlled by GacA (53), as well as by
Figure 3. Cell-to-cell signaling systems. Cell-to-cell
signaling systems are composed of two genes.
The  I gene encodes an autoinducer synthase and the
R gene encodes a transcriptional activator protein (R-
protein). The autoinducer synthase is responsible for
the synthesis of an autoinducer molecule (AI), which
crosses the cell membrane. With increasing cell-
density the intracellular concentration of AI reaches
a threshold level, and the AI then binds to the
transcriptional activator. The complex R-protein/AI
activates the expression of specific target genes.555 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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Vfr, which is required for the transcription of
lasR  (54). An inhibitor, RsaL, that represses the
transcription of lasI, has also been described (de
Kievit et al., unpub. data). The multiple
regulatory levels of the  las cell-to-cell signaling
system and the various genes under its
control highlight the importance of this
system for P. aeruginosa.
The rhl Cell-to-Cell Signaling System of
P. aeruginosa
P. aeruginosa has a second cell-to-cell
signaling system, named the rhl system because
of its ability to control the production of
rhamnolipid. This system is composed of rhlI, the
C4-HSL (N-butyrylhomoserine lactone, previ-
ously named PAI-2 or BHL) autoinducer synthase
gene, and the rhlR gene encoding a transcrip-
tional activator protein (Figure 4) (55-59). This
system regulates the expression of the rhlAB
operon that encodes a rhamnosyltransferase
required for rhamnolipid production (60). The
rhl  system is also necessary for optimal
production of LasB elastase, LasA protease,
pyocyanin, cyanide, and alkaline protease
(53,57,61,62). Therefore, like the las cell-to-cell
signaling system, the rhl system, sometimes
referred to as vsm (virulence secondary
metabolites), regulates the expression of various
extracellular virulence factors of P. aeruginosa.
Interestingly, the rhl system also regulates the
expression of rpoS, which encodes a stationary
sigma factor (dS) involved in the regulation of
various stress-response genes (63,64).
The Cell-to-Cell Signaling Hierarchy in
P. aeruginosa
Recent data have shown that the las and rhl
cell-to-cell signaling systems of P. aeruginosa
interact. Both systems are highly specific in that
their respective autoinducers are unable to
activate the transcriptional activator protein of
the other system (i.e., 3-oxo-C12-HSL cannot
activate RhlR, and C4-HSL cannot activate
LasR) (57,62). It has also been shown that the R-
protein/autoinducer complexes prefer certain
promoters that they will activate; LasR/3-oxo-
C12-HSL preferentially activates lasB over rhlA,
and RhlR/C4-HSL preferentially activates rhlA
over lasB (57,62). However, neither system is
completely independent of the other. The LasR/
3-oxo-C12-HSL complex activates the expression
of  rhlR placing the las system in a cell-to-cell
signaling hierarchy above the rhl system (Figure
4) (63,65). Moreover, 3-oxo-C12-HSL can bind to
RhlR, blocking the binding of C4-HSL to its
transcriptional activator rhlR (65). The las
Figure 4. The cell-to-cell signaling circuitry of P.
aeruginosa.  The  las cell-to-cell signaling system
controls the rhl cell-to-cell signaling system in a
hierarchy cascade. The LasR/3-oxo-C12-HSL com-
plex activates the transcription of rhlR, and 3-oxo-
C12-HSL blocks the activation of RhlR by C4-HSL.
The las system itself is controlled positively by Vfr
and GacA, and negatively by RsaL. 3-oxo-C12-HSL is
required for biofilm differentiation and has
immunomodulatory activity. Both cell-to-cell signal-
ing systems regulate the expression of numerous
genes (lasB: LasB elastase, lasA: LasA elastase,
toxA: exotoxin A, aprA: alkaline protease, xcpP and
xcpR: genes of the xcp secretory pathway, rhlAB:
rhamnosyltransferase required for rhamnolipid
production, rpoS: stationary phase sigma factor).556 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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system therefore controls the rhl system at both
a transcriptional and posttranslational level.
Another yet unidentified regulatory mechanism
directly influencing the expression of rhlRI has
been suggested (63). Rhl system regulation of
such important genes as rpoS could explain why
multiple levels of controls are required for its
tight regulation.
Cell-to-Cell Signaling: A Powerful System to
Overcome Host Defenses during Acute
Infection
Cell-to-cell signaling systems might enable
P. aeruginosa to overcome host defense
mechanisms. Isolated production of extracellular
virulence factors by a small number of bacteria
would probably lead to an efficient host response
neutralizing these compounds. However, the
coordinated expression of virulence genes by an
entire bacterial population once a certain density
has been reached might allow P. aeruginosa to
secrete extracellular factors only when they can
be produced at high enough levels to overcome
host defenses. These factors could alter the
precarious balance between host defenses and
production of bacterial toxins, leading to
invasion of blood vessels, dissemination, sys-
temic inflammatory-response syndrome, and
finally death. Even appropriate antibiotic
therapies are often unable to stop this course;
therefore, the process must be blocked early,
before virulence gene expression can be
coordinated.
Biofilms and Cell-to-Cell Signaling
The most striking feature of persistent P.
aeruginosa infections in CF patients is the
selection of mucoid mutants producing the
exopolysaccharide alginate (a polymer of
mannuronic and guluronic acid) (11). These
mutant bacteria grow inside a biofilm (defined as
microcolonies surrounded by an
exopolysaccharide) as a survival strategy
because the surrounding matrix protects
bacteria from phagocytes and complement
activity (11). P. aeruginosa growing in an
alginate slime matrix are resistant to
antibiotics (e.g., aminoglycosides, ß-lactam
antibiotics, fluoroquinolones) and disinfectants
(11). The exact nature of the increased resistance
is unclear but has been attributed to slow
growth, penetration barriers, ß-lactamase pro-
duction, and other factors. P. aeruginosa also
produces other less well-defined biofilms
essential in the colonization of indwelling
devices such as catheters. Recently, the las cell-
to-cell signaling system has been shown to be
involved in the differentiation of P. aeruginosa
biofilms (66). A mutant defective in the
production of 3-oxo-C12-HSL formed an abnor-
mal biofilm that, in contrast to the wild type
biofilm, was sensitive to low concentrations of
the detergent sodium dodecyl sulfate (SDS).
Furthermore, the addition of 3-oxo-C12-HSL to
the culture media restored production of a
differentiated, SDS-resistant biofilm by the
mutant (66). Whether the formation of an
undifferentiated biofilm renders this mutant
more sensitive to antibiotics is still unknown.
Also unclear is whether 3-oxo-C12-HSL is
required for the differentiation of alginate
biofilms. The link between 3-oxo-C12-HSL and
biofilm differentiation highlights the broad
range of systems controlled by cell-to-cell
signaling in P. aeruginosa.
Interference with Cell-to-Cell Signaling: A
Potential Therapeutic Approach against P.
aeruginosa
The increasing emergence of bacterial
strains resistant to antibacterial drugs is a major
challenge.  P. aeruginosa is one of the most
problematic human pathogens, showing intrin-
sic resistance to many structurally unrelated
antibiotics. Resistance mechanisms include low
outer membrane permeability or multidrug
efflux pumps (tetracycline, imipenem,
fluoroquinolones, aminoglycosides) or produc-
tion of antibiotic modifying enzymes
(aminoglycosides, ß-lactams) (67,68). Previous
exposure to antibiotics often leads to multidrug-
resistant P. aeruginosa strains. Moreover, the
eradication of colonization with P. aeruginosa is
almost impossible in CF patients because of the
emergence of multidrug-resistant strains and
the protective effects of alginate (69). Therefore,
major efforts have been made to find new
therapeutic interventions against P. aeruginosa.
A tempting approach is to reduce the production
of extracellular virulence factors. In this regard,
the interference with cell-to-cell signaling
systems is very attractive. Experimental
evidence for effective interference with cell-to-
cell signaling systems has been recently557 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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provided by the use of autoinducer analogs (70-72)
or furanone compounds (73). The LasR/3-oxo-
C12-HSL complex, which plays a central role
in controlling virulence gene expression in
P. aeruginosa, is essential not only for the
production of elastase and other proteases
required for tissue invasion but also for the
control of the rhl cell-to-cell signaling system in a
hierarchical cascade and for the differentiation
of biofilm. Mutants with a nonfunctional las cell-
to-cell signaling system are unable to produce
several virulence factors (including elastase) and
have significantly reduced virulence in a
neonatal mouse pneumonia model (37). There-
fore, the LasR/3-oxo-C12-HSL complex has
become a potential target for new therapeutic
interventions. Analogs of 3-oxo-C12-HSL (74)
are under investigation for their ability to act as
3-oxo-C12-HSL antagonists, which block activa-
tion of LasR and thereby interfere with virulence
gene expression. The fact that 3-oxo-C12-HSL
can block the bioactivity of C4-HSL (65) suggests
that it might be possible to interfere efficiently
with cell-to-cell signaling in P. aeruginosa. As
elements essential for the synthesis of
autoinducers have recently been described,
drugs inhibiting the biosynthesis process could
also be designed (75-80). These approaches could
reduce the production of virulence factors, and
by interfering with biofilm differentiation they
could also render colonizing P. aeruginosa more
susceptible to antibiotics and biocides. Combina-
tion therapies, including antibiotics and drugs
reducing virulence factor production, might
have an important role in the treatment of CF
and intensive-care patients.
As with any therapeutic approach against
P. aeruginosa, the possible emergence of
mutations that would prevent the desired effect
is a concern. We have recently described
spontaneous mutants that were restored in the
production of extracellular virulence factors
(elastase and rhamnolipid) in the absence of a
functional las cell-to-cell signaling system (81).
We were unable to isolate mutants restored in
virulence factor production when both the las
and the rhl cell-to-cell signaling systems were
deficient. These results suggest that therapeutic
interventions directed only against the las cell-
to-cell signaling system are likely to fail because
of the emergence of resistant strains able to
produce virulence factors despite an inactive
las system (81). However, if both the las and
the rhl cell-to-cell signaling systems are blocked,
P. aeruginosa might be unable to restore the
production of cell-to-cell signaling dependent
virulence factors; this approach may efficiently
reduce virulence factor production and high
death rates associated with P. aeruginosa.
Cell-to-Cell Signaling Systems in Other
Human Gram-Negative Pathogens
Other gram-negative human pathogens
including  Serratia marcescens, S. liquefaciens,
Aeromonas hydrophila, Vibrio cholerae, V.
parahaemoliticus, Yersinia enterocolitica,
Enterobacter agglomerans, Hafnia alvei, and
Rahnella aquatis have been shown to produce
homoserine lactone-based autoinducer mol-
ecules. These organisms are thought to contain
cell-to-cell signaling systems analogous to the las
and  rhl  systems of P. aeruginosa (39,40).
Burkholderia cepacia (formerly known as
Pseudomonas cepacia) is an opportunistic
pathogen responsible for fatal pulmonary
infections in CF patients (11). Virulence factor
production of this pathogen can be enhanced by
P. aeruginosa exoproducts, and this interspecies
communication may be due to homoserine-
lactone signals (82). Whether B. cepacia contains
cell-to-cell signaling systems is still unknown. As
the number of bacteria known to use cell-to-cell
signaling systems increases, therapeutic inter-
ference with cell-to-cell signaling might expand
to other human pathogens.
Conclusions
The pathogenesis of P. aeruginosa is clearly
multifactorial as underlined by the large number
of virulence factors and the broad spectrum of
diseases the bacterium causes. Many of the
extracellular virulence factors required for
tissue invasion and dissemination are controlled
by cell-to-cell signaling systems involving
homoserine lactone-based signal molecules and
specific transcriptional activator proteins. These
regulatory systems enable P. aeruginosa to
produce virulence factors in a coordinated, cell-
densitydependent manner that could allow the
bacteria to overwhelm the host defense
mechanisms. Interference with cell-to-cell sig-
naling dependent virulence factor production is a
promising therapeutic approach for reducing
illness and death associated with P. aeruginosa558 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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colonization and infection. The growing number
of human pathogens found to contain cell-to-cell
signaling systems highlights the importance of
exploring interference with bacterial cell-to-cell
signaling for new therapeutic interventions.
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